Cargando…
Large-Scale Screening of HCMV-Seropositive Blood Donors Indicates that HCMV Effectively Escapes from Antibodies by Cell-Associated Spread
Immunoglobulins are only moderately effective for the treatment of human cytomegalovirus (HCMV) infections, possibly due to ineffectiveness against cell-associated virus spread. To overcome this limitation, we aimed to identify individuals with exceptional antibodies in their plasma that can efficie...
Autores principales: | Falk, Jessica Julia, Winkelmann, Martina, Laib Sampaio, Kerstin, Paal, Caroline, Schrezenmeier, Hubert, Alt, Mira, Stanton, Richard, Krawczyk, Adalbert, Lotfi, Ramin, Sinzger, Christian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6163834/ https://www.ncbi.nlm.nih.gov/pubmed/30223489 http://dx.doi.org/10.3390/v10090500 |
Ejemplares similares
-
HCMV Spread and Cell Tropism are Determined by Distinct Virus Populations
por: Scrivano, Laura, et al.
Publicado: (2011) -
Alveolar Macrophages Isolated Directly From Human Cytomegalovirus (HCMV)–Seropositive Individuals Are Sites of HCMV Reactivation In Vivo
por: Poole, Emma, et al.
Publicado: (2015) -
NK Cells from RAG- or DCLRE1C-Deficient Patients Inhibit HCMV
por: Wu, Zeguang, et al.
Publicado: (2019) -
ELISPOT assays with pp65 peptides or whole HCMV antigen are reliable predictors of immune control of HCMV infection in seropositive kidney transplant recipients
por: Zavaglio, Federica, et al.
Publicado: (2023) -
HCMV Infection and Apoptosis: How Do Monocytes Survive HCMV Infection?
por: Collins-McMillen, Donna, et al.
Publicado: (2018)